We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
301
Deere & Co
DE
$168B
$757K 0.1%
1,823
-79
-4% -$30.3K
CNNE icon
302
Cannae Holdings
CNNE
$649M
$756K 0.1%
31,615
+7,811
+33% +$220K
THRY icon
303
Thryv Holdings
THRY
$108M
$754K 0.1%
+26,801
New +$841K
SNDX icon
304
Syndax Pharmaceuticals
SNDX
$1.82B
$753K 0.1%
+43,300
New +$729K
ANDE icon
305
Andersons Inc
ANDE
$2.22B
$751K 0.1%
14,942
+3,144
+27% +$132K
BV icon
306
BrightView Holdings
BV
$1.07B
$751K 0.1%
55,152
-18,003
-25% -$243K
CNDT icon
307
Conduent
CNDT
$264M
$751K 0.1%
145,570
-3,318
-2% -$16.3K
SRNE
308
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$748K 0.1%
321,129
+286,428
+825% +$893K
FCEL icon
309
FuelCell Energy
FCEL
$1.63B
$744K 0.1%
4,304
+1,772
+70% +$281K
CNP icon
310
CenterPoint Energy
CNP
$26.8B
$741K 0.1%
24,186
+16,527
+216% +$464K
RNR icon
311
RenaissanceRe
RNR
$13.4B
$739K 0.1%
+4,660
New +$724K
MLCO icon
312
Melco Resorts & Entertainment
MLCO
$2.14B
$735K 0.1%
+96,231
New +$925K
DG icon
313
Dollar General
DG
$27.9B
$732K 0.1%
+3,286
New +$698K
EYE icon
314
National Vision
EYE
$1.81B
$728K 0.1%
+16,700
New +$677K
CNOB icon
315
Center Bancorp
CNOB
$1.78B
$727K 0.1%
22,717
+10,757
+90% +$360K
LXFR icon
316
Luxfer Holdings
LXFR
$458M
$727K 0.1%
43,255
+12,564
+41% +$222K
FNB icon
317
FNB Corp
FNB
$6.75B
$724K 0.1%
58,151
+33,261
+134% +$438K
WD icon
318
Walker & Dunlop
WD
$1.53B
$723K 0.1%
+5,583
New +$766K
KO icon
319
Coca-Cola
KO
$375B
$720K 0.1%
+11,607
New +$706K
WAT icon
320
Waters Corp
WAT
$39.9B
$719K 0.1%
+2,315
New +$753K
RBBN icon
321
Ribbon Communications
RBBN
$383M
$717K 0.1%
232,049
+17,421
+8% +$71.4K
TDAY
322
USA Today Co
TDAY
$1.06B
$716K 0.1%
158,799
-131,327
-45% -$666K
GNK icon
323
Genco Shipping & Trading
GNK
$1.1B
$715K 0.1%
30,281
+10,762
+55% +$199K
NSTG
324
DELISTED
NanoString Technologies, Inc.
NSTG
$715K 0.1%
+20,562
New +$708K
EXPE icon
325
Expedia Group
EXPE
$37.3B
$713K 0.1%
3,645
+2,481
+213% +$464K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.